FDA Advisers Vote Unanimously Recommending Authorization of Moderna's Coronavirus Vaccine
After a full day of discussions, the Food and Drug Administration (FDA) advisory committee voted unanimously to recommend authorization of mRNA-1273, Moderna's (NASDAQ: MRNA) coronavirus vaccine. There was one abstention among the 21 votes by outside experts on the panel.
The FDA doesn't have to follow the recommendation of the advisory committee, but considering how positive the agency's review of the vaccine was, it seems highly likely regulators will issue an emergency use authorization (EUA) for mRNA-1273. Based on last week's schedule for Pfizer and BioNTech's coronavirus vaccine, BNT162b2, the FDA could issue the EUA tomorrow.
Image source: Getty Images.
Source Fool.com
